穴位埋线疗法安全性的系统综述
该综述检索截至2020年1月的中英文数据库,纳入45项随机对照试验和16例病例报告,共620例不良事件。最常见的埋线不良事件为硬结、出血瘀斑、红肿、发热和疼痛,占75.35%(425/564),多为轻度;局部反应发生率为9.83%(480/4,882),全身反应仅1.27%(62/4,882)。
要点
- 埋线疗法不良事件常见(11.09%),以局部轻度反应为主。
- 2013至2017年使用羊肠线的严重不良事件仅5例(0.1%),对症治疗后均恢复。
- 新型可吸收缝线广泛应用后严重不良事件已少见。
核心结论
- 证据显示埋线疗法相对安全便捷,尤其在应用新型可吸收外科缝线后。
- 提高操作者技能、规范操作和关注患者状况可降低不良事件发生率。
研究设计与样本
- 系统综述检索CNKI、CBMdisc、万方、维普及PubMed、MEDLINE、EMBASE、Web of Science,截至2020年1月。
- 纳入45项随机对照试验和16例病例报告,共620例不良事件。
主要发现
- 最常见不良事件为硬结、出血瘀斑、红肿、发热和疼痛,占75.35%(425/564),多为轻度。
- 局部反应发生率为9.83%(480/4,882),全身反应仅1.27%(62/4,882)。
- 不良事件总发生率为11.09%。
- 2013至2017年使用羊肠线的严重不良事件仅5例(0.1%),对症治疗后均恢复无后遗症。
- 最罕见不良事件为癫痫、月经不调、皮肤溃疡、线体不吸收和脂肪液化,各1例,但并非均与埋线有明确因果关系。
关键数值与推荐
- 不良事件总发生率为11.09%。
- 局部反应发生率为9.83%(480/4,882),全身反应为1.27%(62/4,882)。
- 常见不良事件占75.35%(425/564)。
- 使用羊肠线的严重不良事件为0.1%(5例)。
临床怎么用
- 临床可向患者说明埋线疗法不良事件常见但多为轻度局部反应。
- 优先使用新型可吸收外科缝线以降低严重不良事件风险。
- 规范操作并评估患者状况有助于减少不良事件。
局限性
- 并非所有不良事件均与埋线疗法有明确因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the safety of thread embedding acupuncture therapy (TEAT) and discuss the prevention and treatment of some adverse events (AEs). METHODS: Review of databases, including China National Knowledge Infrastructure (CNKI), CBMdisc, Wanfang, VIP databases and English literature published in PubMed, MEDLINE, EMBASE and Web of Science, were searched from their inception to January 2020, randomized controlled trials (RCTs) and case reports in which AEs with TEAT were included. Cochrane Collaboration's tool and RevMan V.5.3.3 software were used to evaluate the quality of the studies. RESULTS: A total of 61 studies (45 RCTs and 16 case reports) with 620 cases of AEs were included in this review. These studies were published in two countries: China and South Korea. Twenty eight kinds of AEs were summarized. The most common AEs were induration, bleeding and ecchymosis, redness and swelling, fever, and pain. They were accounted for 75.35% (425/564) in the review, and most of them were mild. The rarest AEs were epilepsy, irregular menstruation, skin ulcer, thread malabsorption, and fat liquefaction, with 1 case each. But not all of them had clear causal relationship with TEAT. Most of the AEs were local reactions [with incidence of 9.83% (480/4,882)] and systemic reactions accounted for only 1.27% (62/4,882). Although the included studies showed that AEs were very commonly encountered (11.09%), only 5 cases of severe AEs reported from 2013 to 2017 (0.1%) by using catgut thread, which are rarely seen nowdays with the wide use of new absorbable surgical suture. All of the severe AEs were recovered after symptomatic treatment with no sequelae. CONCLUSIONS: The evidence showed that TEAT is a relatively safe and convenient therapy especially since application of new absorbable surgical suture. Improving practitioner skills, regulating operations, and paying attention to the patients' conditions may reduce the incidence of AEs and improve safety of TEAT.
引用
- Huang JJ, Liang JQ, Xu XK, et al. Safety of Thread Embedding Acupuncture Therapy: A Systematic Review. Chin J Integr Med. 2021. PMID: 33893986. doi:10.1007/s11655-021-3443-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。